|
|
Volumn 316, Issue 9, 2016, Pages 913-915
|
|
VA extends new hepatitis C drugs to all veterans in its health system
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
DASABUVIR PLUS OMBITASVIR PLUS PARITAPREVIR PLUS RITONAVIR;
LEDIPASVIR;
SOFOSBUVIR;
ARTICLE;
BUDGET;
DRUG COST;
DRUG INDUSTRY;
GOVERNMENT;
HEALTH CARE SYSTEM;
HEALTH SERVICE;
HEPATITIS C;
HUMAN;
PATIENT CARE;
PATIENT EDUCATION;
PRIORITY JOURNAL;
SCREENING;
VETERAN;
UNITED STATES;
ANTIVIRAL AGENTS;
HEPATITIS C;
HUMANS;
UNITED STATES;
UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;
VETERANS;
|
|
EID: 84995752771
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2016.8669 Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
